全文获取类型
收费全文 | 99006篇 |
免费 | 7496篇 |
国内免费 | 5732篇 |
专业分类
耳鼻咽喉 | 723篇 |
儿科学 | 2542篇 |
妇产科学 | 1254篇 |
基础医学 | 17363篇 |
口腔科学 | 2100篇 |
临床医学 | 9011篇 |
内科学 | 14369篇 |
皮肤病学 | 2084篇 |
神经病学 | 5434篇 |
特种医学 | 2071篇 |
外国民族医学 | 34篇 |
外科学 | 4980篇 |
综合类 | 18864篇 |
现状与发展 | 28篇 |
一般理论 | 1篇 |
预防医学 | 6866篇 |
眼科学 | 1514篇 |
药学 | 11005篇 |
18篇 | |
中国医学 | 2599篇 |
肿瘤学 | 9374篇 |
出版年
2024年 | 198篇 |
2023年 | 1049篇 |
2022年 | 2286篇 |
2021年 | 3083篇 |
2020年 | 2690篇 |
2019年 | 2517篇 |
2018年 | 2404篇 |
2017年 | 2662篇 |
2016年 | 2948篇 |
2015年 | 3066篇 |
2014年 | 5100篇 |
2013年 | 6156篇 |
2012年 | 5419篇 |
2011年 | 6559篇 |
2010年 | 5384篇 |
2009年 | 5202篇 |
2008年 | 5568篇 |
2007年 | 5966篇 |
2006年 | 5508篇 |
2005年 | 5323篇 |
2004年 | 4650篇 |
2003年 | 4155篇 |
2002年 | 3631篇 |
2001年 | 3250篇 |
2000年 | 2869篇 |
1999年 | 2514篇 |
1998年 | 2197篇 |
1997年 | 1871篇 |
1996年 | 1404篇 |
1995年 | 1357篇 |
1994年 | 1101篇 |
1993年 | 759篇 |
1992年 | 631篇 |
1991年 | 466篇 |
1990年 | 382篇 |
1989年 | 262篇 |
1988年 | 217篇 |
1987年 | 181篇 |
1986年 | 140篇 |
1985年 | 218篇 |
1984年 | 179篇 |
1983年 | 122篇 |
1982年 | 139篇 |
1981年 | 115篇 |
1980年 | 80篇 |
1979年 | 59篇 |
1978年 | 44篇 |
1977年 | 43篇 |
1976年 | 37篇 |
1973年 | 18篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
Defining con-founders that affect the reliability of diagnostic tests for coronavirus disease 2019 is vital to breaking the chain of infection. The elderly population is a higher risk group for the emerging virus. However, gender seems to exert a critical role in modifying the infection risk among women owing to hormonal changes. The menopause transition is an exceptional period for older women where the protective and immunomodulatory effects of the estrogen hormone are lost. Accordingly, attention should be given to postmenopausal women since they will have an increased risk compared to their pre-menopausal peers. 相似文献
4.
5.
目的探讨脊髓小脑共济失调2型(SCA2)致病基因ATXN2异常等位基因中间重复个体的表型和分子遗传学特点。方法针对2005—2018年中日友好医院神经科运动障碍与神经遗传病研究中心收集的1383个常染色体显性遗传共济失调家系的先证者和部分家系成员,采用荧光标记毛细管电泳片段分析方法进行动态突变检测,对携带ATXN2基因中间重复的个体进行临床表型和遗传特征分析。结果共检出163个家系(包含先证者和家系成员共203人)携带异常扩展的ATXN2基因CAG重复序列,其中93个家系中有107例的异常扩展等位基因重复次数在29~34次之间。在其中的20个亲子对中,父系遗传16个,异常等位基因的代间扩展增加0~28次,母系遗传4个,异常等位基因的代间扩展增加0~4次。结论对于临床拟诊SCA2家系患者,需对其亲代或成年子代个体进行ATXN2基因检测,以免漏诊。动态突变基因检测有助于识别中间重复的个体,对明确家系致病基因和遗传咨询至关重要。 相似文献
6.
7.
《Clinical microbiology and infection》2022,28(8):1120-1125
ObjectivesOur aim was to evaluate the effect of the updated European Organization for Research and Treatment of Cancer (EORTC) and Mycoses Study Group 2019 definitions for invasive pulmonary aspergillosis (IPA) on patient classification and the related all-cause 12-week mortality.MethodsIn this retrospective cohort study from our tertiary care centre, we reclassified patients with haematological malignancy who underwent bronchoalveolar lavage between 2014 and 2019 for suspected IPA using the novel EORTC 2019 criteria. We performed receiver operating characteristic curve analysis to define the optimal cut-off for positive PCR and galactomannan and present survival analyses and their possible association with these diagnostic criteria through post hoc comparisons with log rank and Cox regression.ResultsFrom 323 episodes of suspected IPA in 282 patients, 73 were reclassified: 31 (42.5%) from possible to probable IPA, 5 (6.8%) from EORTC criteria not met to probable IPA, and 37 (50.7%) from EORTC criteria not met to possible IPA. Probable IPA increased therefore 11.1% (64/323, 19.8% to 100/323, 30.9%), mostly due to positive PCR (31/36, 86.1%). There was no difference in mortality between newly defined possible and probable IPA (log rank p = 0.950). Mortality was higher in probable cases with lower cycle thresholds (Ct values) versus higher Ct values (p = 0.004). Receiver operating characteristic curve analysis showed an optimal Ct value cut-off of 36.8 with a sensitivity of 75% (95% CI 64.9%–85.1%) and a specificity of 61.7% (95% CI 53.5–69.9) for 12-week mortality.DiscussionThe new EORTC criteria led to 11.1% more probable IPA diagnoses, mostly due to Aspergillus PCR. Restricting positive PCR to below a certain threshold might improve the discrimination of the new EORTC IPA categories for mortality. 相似文献
8.
9.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
10.